The emerging treatment of this peptide represents a major development in the care of type 2 diabetes. Different to existing drugs, tirzepatide targets multiple pathways – the GLP-1 hormone and GIP – leading to https://tirzepatidepeptide501055.blogpixi.com/42359568/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment